Clinical Trial Update: Safety of Estrogens in Lupus: Birth Control Pills [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing the safety of estrogen-containing birth control pills in patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Estrogen-containing oral contraceptives (ethinyl estradiol-containing oral contraceptives)

Snippet

Sponsor: NYU Langone Health | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED